Review of antihyperlipedemic herbal medicine

Journal of Medicinal Plants

Volumn 4, Issue 15, 2005, Pages 9-20

  Fallah Huseini, H ^a   Fakhrzadeh, H ^b   Dastpak, A ^a   Azarabadi, M ^c   Mohtashami Tokabny, R ^c  

^a Institute of Medicinal Plants Iran   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Cholesterol; Herbal medicine; Hyperlipedimia

Indexed keywords

ANTILIPEMIC AGENT; HERBACEOUS AGENT;

CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; NONHUMAN; PRESCRIPTION; REVIEW; RISK FACTOR; SIDE EFFECT;

ZEA MAYS;

EID: 28644451503     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Eisenberg DM, David RB and Ettner SL. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569-1575.
2. Hoerger TJ and Bala MV. Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults. Am. J. Cardiol. 1998; 82: 61-65.
3. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251: 351-364.
4. Bhardwaj PK, Dasgupta DJ, Prashar BS and Kaushal SS. Control of hyperglycaemia and hyperlipidaemia by plant product. J. Assoc Physicians India 1994; 42: 33-35.
5. Bohm H, Boeing H, Hempel J, Raab B and Kroke A. Flavonols, flavone and anthocyanins as natural antioxidants of food and their possible role in the prevention of chronic diseases. Z Ernahrungswiss. 1998; 37: 147-163.
6. Hou L, Zhou B, Yang L and Liu ZL. Inhibition of human low density lipoprotein oxidation by flavonols and their glycosides. Chem. Phys. Lipids. 2004; 129: 209-219.
7. Mennen LI, Sapinho D, de Bree A, Arnault N, Bertrais S, Galan P. Hercberg S. Consumption of foods rich in flavonoids is related to a decreased cardiovascular risk in apparently healthy French women. J. Nutr. 2004; 134: 923-6.
8. Amirghofran Z, Azadbakht M and Karimi MH. Evaluation of the immunomodulatory effects of five herbal plants. J. Ethnopharmocol. 2000; 72: 167-172.
9. Brand N. Cynara scolamus L. - the artichoke Z. Phytother. 1990; 11: 169- 175.
10. Kirchhoff R, Beckers CH and Kirchhoff GM. Increase in choleresis by means of artichoke extract. Phytomedicine. 1994; 1: 107-115.
11. Blumenthal M. The Complete German Commission E Monographs, Therapeutic Guide to Herbal Medicines. Boston. Mass Integrative Medicine Communications. 1998, pp: 84.
12. Kupke D, von Sanden H and Trinczek-Gartner H. An evaluation of the choleretic activity of a plant-based cholagogue. Z. Allgemeinmed. 1991; 67: 1046-1058.
13. Matuschowski P. Testing of Cynara scolymus in the isolated perfused rat liver. 43rd Ann. Congr. Soc. Med. Plant. Res. Halle. Sept 1996: 3-7.
14. Gebhart R. Prevention of taurolithocholate induced hepatic bile canalicular distortions by HPLC-characterized extracts of artichoke (Cynara scolymus) leaves. Planta Med. 2002; 68: 776-779.
15. Kraft K. Artichoke leaf extract-recent findings reflecting effects on lipid metabolism, liver and gastrointestinal tracts. Phytomedicine. 1997; 4: 369-378.
16. Englisch W, Beckers C, Unkauf M, Ruepp M and Zinserling V. Efficacy of Artichoke dry extract in patients with hyperlipoproteinemia. Arzneimittelforschung 2000; 50: 260-265.
17. Kirchhoff R, Beckers Ch, Kirchhoff GM, Trinczek-Gartner H, Petrowicz O and Reimann HJ. Increase in choleresis by means of artichoke extract. Phytomedicine. 1994; 1: 107-115.
18. Health Encyclopedia The Natural Pharmacist: Herbs & Supplements.http://healthinfo.healthgate.com. 2005.
19. Blinker F. Herb Contraindications and Drug Interactions. Sandy. Ore: Eclectic Medical Publications. 1998.
20. Castleman M. The Healing Herbs: The Ultimate Guide to the Curative Power of Nature's Medicines. Emmaus. Pa: Rodale Press. 1991.
21. Malinow MR, McLaughlin P and Bardana EJ. Elimination of toxicity from diets containing alfalfa seeds. Food. Chem. Toxicol. 1984; 22: 583-7.
22. Kurzer MS and Xu X. Dietary phytoestrogens. Annu. Rev. Nutr. 1997; 17: 353-381.
23. Shemesh M, Lindrer HR and Ayalon N. Affinity of rabbit uterine oestradiol receptor for phyto-oestrogens and its use in a competitive protein-binding radioassay for plasma coumestrol. J. Reprod. Fertil. 1972; 29: 1-9.
24. De Leo V, Lanzetta D and Cazzavacca R. Treatment of neurovegetative menopausal symptoms with a phytotherapeutic agent. Minerva Ginecol. 1998; 50: 207-211.
25. Colodny LR, Montgomery A and Houston M. The role of esterin processed alfalfa saponins in reducing cholesterol. J. Am. Nutraceutical. Assoc. 2001; 3: 6-15.
26. Malinow MR, Bardana EJ and Pirofsky B. Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science. 1982; 216: 415-417.
27. Sharma RD, Sarkar A and Hazra DK. Use of fenugreek seed powder in the management of non-insulin dependent diabetes mellitus. Nutr. Res. 1996; 16: 1331-9.
28. Madar Z, Abel R and Samish S. Glucose-lowering effect of fenugreek in non-insulin dependent diabetics. Eur. J. Clin. Nutr. 1988; 42: 51-4.
29. Sharma RD, Raghuram TC and Rao NS. Effect of fenugreek seeds on blood glucose and serum lipids in type I diabetes. Eur. J. Clin. Nutr. 1990; 44: 301-6.
30. Leung AY and Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. 2nd ed. New York, NY: Wiley; 1996: 243-4.
31. Schulz V, Hansel R and Tyler VE. Rational Phytotherapy: A Physicians' Guide to Herbal Medicine. 3rd ed. Berlin. Germay. Springer-Verlag: 1998, 112.
32. Reuter HD and Sendl A. Allium sativum and Allium ursinum: Chemistry, pharmacology and medicinal applications. Econ. Med. Plant. Res. 1994; 6: 56-113.
33. Warshafsky S, Kamer RS and Sivak SL. Effect of garlic on total serum cholesterol. A metaanalysis. Ann. Intern. Med. 1993; 119: 599-605.
34. Isaacsohn JL, Moser M and Stein EA. Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch. Intern. Med. 1998; 158: 1189-1194.
35. Kannar D, Wattanapenpaiboon N and Savige GS. Hypocholesterolemic effect of an enteric-coated garlic supplement. J. Am. Coll. Nutr. 2001; 20: 225-231.
36. Efendy JL, Simmons DL and Campbell GR. The effect of the aged garlic extract, "Kyolic," on the development of experimental atherosclerosis. Atherosclerosis. 1997; 132: 37-42.
37. Koscielny J, Klussendorf D and Latza R. The antiatherosclerotic effect of Allium sativum. Atherosclerosis. 1999; 144: 237-249.
38. Breithaupt-Grogler K, Ling M and Boudoulas H. Protective effect of chronic garlic intake on elastic properties of aorta in the elderly. Circulation 1997; 96: 2649-2655.
39. Sumiyoshi H, Kanezawa A and Masamoto K. Chronic toxicity test of garlic extract in rats. J. Toxicol. Sci. 1984; 9: 61-75.
40. Anderson JW, Johnstone BM and Cooke-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 1995; 333: 276-281.
41. Teixeira SR, Potter SM and Weigel R. Effects of feeding 4 levels of soy protein for 3 and 6 week on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am. J. Clin. Nutr. 2000; 71: 1077-1084.
42. Schonfeld JV, Weisbrod B and Muller MK. Silibinin, a plant extract with antioxidant and membrane stabilizing properties, protects exocrine pancreas from cyclosporin toxicity. CMLS 1997; 53: 917-920.
43. Svagera Z, Skottova N, Vana P, Vecera R, Urbanek K, Belejova M, Kosina P and Simanek V. Plasma lipoproteins in transport of silibinin, an antioxidant flavonolignan from Silybum marianum. Phytother. Res. 2003; 17: 524-530.
44. Skottova N, Krecman V and Simanek V. Activities of silymarin and its flavonolignans upon low density lipoprotein oxidizability in vitro. Phytother. Res. 1999; 13: 535-7.
45. Nassuato G, Iemmolo RM, Strazzabosco M, Lirussi F, Deana R, Francesconi MA, Muraca M, Passera D, Fragasso A, Orlando R, Csomos G and Okolicsanyi L. Effect of Silibinin on biliary lipid composition experimental and clinical study. J. Hepatology. 1991; 12: 290-5.
46. Somogyi A, Ecsedi GG, Blazovics A, Miskolczi K, Gergely P and Feher J. Short term treatment of type II hyperlipoproteinaemia with silymarin. Acta. Med. Hung. 1989; 46: 289-95.
47. Burnham TH, Sjweain SL and Short RM (eds). Monascus. In: The Review of Natural Products. St. Louis, MO: Facts and Comparisons, 1997.
48. Li C, Zhu Y and Wang Y. Monascus purpureus-fermented rice (red yeast rice): a natural food product that lowers blood cholesterol in animal models of hypercholesterolemia. Nutr. Res. 1998; 18: 71-81.
49. Heber D, Yip I and Ashley JM. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am. J. Clin. Nutr. 1999; 69: 231-6.
50. Wang J, Lu Z and Chi J. Multicenter clinical trial of the serum lipid-lowering effects of a Monascus purpureus (red yeast) rice preparation from traditional Chinese medicine. Curr. Ther. Res. 1997; 58: 964-77.
51. Satyavati GV. Gum guggul (Commiphora mukul) the success story of an ancient insight leading to a modern discovery. Indian. J. Med. Res. 1988; 87: 327-335.
52. Singh RB, Niaz MA and Ghosh S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc. Drugs Ther. 1994; 8: 659-664.
53. Nityanand S, Srivastava JS and Asthana OP. Clinical trials with gugulipid. A new hypolipidaemic agent. J. Assoc. Physicians India. 1989; 37: 323-328.
54. Gray DS. The clincal uses of dietary fiber. AFP. 1995; 51: 419426.
55. Hunt R, Fedorak R, Frohlich J and McLennan C. Therapeutic role of dietary fibre. Can. Fam. Physician. 1993; 39: 897-910.
56. Bell LP, Hectorne K, Reynolds H, Balm TK and Hunninghake DB. Cholesterol-lowering effects of psyllium hydrophilic mucilloid. JAMA 1989; 261: 3419-3423.
57. Sprecher DL, Harris BV and Goldberg AC. Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high- or low-fat diets. Ann. Intern. Med. 1993; 199: 545-554.
58. Bennet WG and Cerda JJ. Benefits of dietary fiber. Postgrad. Med. 1996; 99: 153-175.
59. Rodriguez-Moran M, Guerrero-Romero F and Lazcano-Burciaga G. Lipid- and glucose- lowering efficacy of Plantago psyllium in type II diabetes. J. Diabetes complications. 1998; 12: 273- 8.
60. Libster M. Herb guide for nurses. Delmar, Thomson Learning, Inc. USA. 2002, pp: 450-7.
61. Seal CJ and Mathers JC. Comparative gastrointestinal and plasma cholesterol responses of rats fed on cholesterol-free diets supplemented with guar gum and sodium alginate. Br. J. Nutr. 2001; 85: 317-324.
62. Maisonnier S, Gomez J, Bree A, Berri C, Baeza E and Carre B. Effects of microflora status, dietary bile salts and guar gum on lipid digestibility, intestinal bile salts, and histomorphology in broiler chickens. Poult Sci. 2003; 82: 805-814.
63. Moundras C, Behr SR, Remesy C and Demigne C. Fecal losses of sterols and bile acids induced by feeding rats guar gum are due to greater pool size and liver bile acid secretion. J. Nutr. 1997; 127: 1068-1076.
64. Frias AC and Sgarbieri VC. Guar gum effects on food intake, blood serum lipids and glucose levels of Wistar rats. Plant Foods Hum. Nutr. 1998; 53: 15-28.
65. PH Groop PH, Aro A, Stenman S and Groop L. Long-term effects of guar gum in subjects with non-insulin-dependent diabetes mellitus. J. Am. Clin. Nutr. 58: 513-8.
66. Karmally W, Montez MG, Palmas W, Martinez W, Branstetter A, Ramakrishnan R, Holleran SF, Haffner SM and Ginsberg HN. Cholesterol-lowering benefits of oat-containing cereal in Hispanic americans. J. Am. Diet. Assoc. 2005; 105: 967-970.
67. Robitaille J, Fontaine-Bisson B, Couture P, Tchernof A and Vohl MC. Effect of an oat branrich supplement on the metabolic profile of overweight premenopausal women. Ann. Nutr. Metab. 2005; 49: 141-8.
68. Handelman GJ, Cao G, Walter MF, Nightingale ZD, Paul GL, Prior RL and Blumberg JB. Antioxidant capacity of oat (Avena sativa L.) extracts. 1. Inhibition of low-density lipoprotein oxidation and oxygen radical absorbance capacity. J. Agric. Food. Chem. 1999; 47: 4888-4893.